Press Enter to search · ESC to close

US Stocks

Eli Lilly to Acquire Calytrix Bio for Up to $1.5B in Cash

Eli Lilly has agreed to acquire Calytrix Bio for up to $1.5 billion in cash. The deal is structured as an all-cash transaction with a total value capped at that amount. No further terms of the agreement were disclosed.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback